TP53BP2 and neoplasm: It was further confirmed that ASPP2 deficiency markedly activated the NF-κB pathway, regulated the expression of inflammatory factors and tumor-related genes in the liver, and promoted DEN-induced hepatocarcinogenesis in mice.